DocGo Inc. Capital Expenditures Incurred but Not yet Paid
DocGo Inc. (DCGO) reported Capital Expenditures Incurred but Not yet Paid of $92.33 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-17.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:CapitalExpendituresIncurredButNotYetPaid · last filed 2026-08-17
- DocGo Inc. capital expenditures incurred but not yet paid for the quarter ending 2026-06-30 was $37.30K.
- DocGo Inc. capital expenditures incurred but not yet paid for the quarter ending 2026-03-31 was $55.03K, a 87.46% decline year-over-year.
- DocGo Inc. capital expenditures incurred but not yet paid for the quarter ending 2025-12-31 was $35.14K, a 79.15% decline year-over-year.
- DocGo Inc. capital expenditures incurred but not yet paid for the quarter ending 2025-09-30 was $4.60K.
- DocGo Inc. capital expenditures incurred but not yet paid for fiscal 2025 was $52.87K, a 76.15% decline from fiscal 2024.
- DocGo Inc. capital expenditures incurred but not yet paid for fiscal 2024 was $221.64K, a 18.30% decline from fiscal 2023.
- DocGo Inc. capital expenditures incurred but not yet paid for fiscal 2023 was $271.29K.
| Period end | Capital Expenditures Incurred but Not yet Paid 3 month | Capital Expenditures Incurred but Not yet Paid 6 month | Capital Expenditures Incurred but Not yet Paid 9 month | Capital Expenditures Incurred but Not yet Paid 12 month |
|---|---|---|---|---|
| 2026-06-30 | $37.30K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-17 | $92.33K 10-Q · filed 2026-08-17 | $127.47K derived: sum of 3 quarters · filed 2026-08-17 | $132.07K derived: sum of 4 quarters · filed 2026-08-17 |
| 2026-03-31 | $55.03K 10-Q · filed 2026-05-11 | $90.17K derived: sum of 2 quarters · filed 2026-05-11 | $94.78K derived: sum of 3 quarters · filed 2026-05-11 | -$330.84K derived: sum of 4 quarters · filed 2026-08-17 |
| 2025-12-31 | $35.14K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $39.74K derived: sum of 2 quarters · filed 2026-03-16 | -$385.87K derived: sum of 3 quarters · filed 2026-08-17 | $52.87K 10-K · filed 2026-03-16 |
| 2025-09-30 | $4.60K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$421.01K derived: sum of 2 quarters · filed 2026-08-17 | $17.73K 10-Q · filed 2025-11-10 | $186.23K derived: sum of 4 quarters · filed 2026-08-17 |
| 2025-06-30 | -$425.61K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-17 | $13.13K 10-Q · filed 2026-08-17 | $181.63K derived: sum of 3 quarters · filed 2026-08-17 | $65.64K derived: sum of 4 quarters · filed 2026-08-17 |
| 2025-03-31 | $438.74K 10-Q · filed 2026-05-11 | $607.24K derived: sum of 2 quarters · filed 2026-05-11 | $491.25K derived: sum of 3 quarters · filed 2026-05-11 | |
| 2024-12-31 | $168.50K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $52.51K derived: sum of 2 quarters · filed 2026-03-16 | $221.64K 10-K · filed 2026-03-16 | |
| 2024-09-30 | -$115.99K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $53.14K 10-Q · filed 2025-11-10 | ||
| 2024-06-30 | $169.13K 10-Q · filed 2025-08-07 | |||
| 2023-12-31 | $271.29K 10-K · filed 2026-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |